Company raises HK$9.89 billion (US$1.29 billion), with the proceeds to be used to support clinical trials and expand production capacity.Company raises HK$9.89 billion (US$1.29 billion), with the proceeds to be used to support clinical trials and expand production capacity. Read More
Business – South China Morning Post
